tiprankstipranks
Affluent Medical Reports Progress and Funding Success
Company Announcements

Affluent Medical Reports Progress and Funding Success

Affluent Medical SA (FR:AFME) has released an update.

Don't Miss Our Christmas Offers:

Affluent Medical, a French MedTech company, discussed its recent operational progress in an interview on Boursorama, highlighting positive FDA feedback on its Kalios device, advancements in the Epygon valve’s clinical studies, and promising results from the Artus device’s pilot trial. The company also secured €1.1 million in non-dilutive funding for the Epygon valve’s development and received positive revisions on its share price target, indicating strong market confidence. Affluent Medical, backed by Truffle Capital, is focused on pioneering minimally invasive implants for heart diseases and urinary incontinence, aiming for commercialization by 2026.

For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskAffluent Medical Enhances Share Liquidity with New Contract
TipRanks European Auto-Generated NewsdeskAffluent Medical SA Gears Up for Scientific Showcases
TipRanks European Auto-Generated NewsdeskAffluent Medical Targets 2026 Market Entry
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App